Swiss National Bank
KZR

Swiss National Bank’s Kezar Life Sciences KZR Stock Holding History

Swiss National Bank’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-11,070
Closed -$346K – 2638
2023
Q1 		$346K Sell
11,070
-1,320
-11% -$76.4K ﹤0.01% 2589
2022
Q4 		$872K Buy
12,390
+1,650
+15% +$122K ﹤0.01% 2409
2022
Q3 		$925K Buy
10,740
+720
+7% +$70K ﹤0.01% 2380
2022
Q2 		$829K Buy
+10,020
New +$884K ﹤0.01% 2462

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Swiss National Bank's KZR Position: Q2 2023 in Review

Swiss National Bank sold out of Kezar Life Sciences (KZR) in Q2 2023, closing a stake of 11,070 shares — an estimated $346K sold.

Swiss National Bank first reported a position in KZR in Q2 2022 and held it in 4 quarters. The position peaked at $925K in Q3 2022. 104 funds tracked by Wall St. Rank hold KZR as of Q2 2023.

  • Swiss National Bank reported no remaining Kezar Life Sciences position as of Q2 2023 after selling out during the quarter.
  • Swiss National Bank sold 11,070 Kezar Life Sciences shares in Q2 2023, an estimated $346K.
  • Swiss National Bank first reported a position in Kezar Life Sciences in Q2 2022 and held it in 4 quarters.
  • Swiss National Bank's Kezar Life Sciences position peaked at $925K in Q3 2022.
  • 104 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2023.

Based on Swiss National Bank's 13F filing for Q2 2023, filed 9 Aug 2023.